Scientists test common Drug's effect on cancer medication
NCT ID NCT05063318
Summary
This study aimed to understand how a common antifungal drug (itraconazole) affects the body's processing of a cancer medication (lurbinectedin). It involved 14 patients with advanced solid tumors who received both drugs in different sequences. The main goal was to measure drug levels in the blood to guide future safe prescribing, not to test the cancer drug's effectiveness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fundacion Jimenez Diaz
Madrid, 28040, Spain
-
Hospital HM Sanchinarro
Madrid, 28050, Spain
Conditions
Explore the condition pages connected to this study.